These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36006326)

  • 1. Multimodal Blockade of the Renin-Angiotensin System Is Safe and Is a Potential Cancer Treatment for Cats.
    Munday JS; Odom T; Dittmer KE; Wetzel S; Hillmer K; Tan ST
    Vet Sci; 2022 Aug; 9(8):. PubMed ID: 36006326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.
    Koide M; Carabello BA; Conrad CC; Buckley JM; DeFreyte G; Barnes M; Tomanek RJ; Wei CC; Dell'Italia LJ; Cooper G; Zile MR
    Am J Physiol; 1999 Feb; 276(2 Pt 2):H350-8. PubMed ID: 9950833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
    Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.
    Antlanger M; Bernhofer S; Kovarik JJ; Kopecky C; Kaltenecker CC; Domenig O; Poglitsch M; Säemann MD
    Ann Med; 2017 Sep; 49(6):525-533. PubMed ID: 28358246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
    Neo JH; Ager EI; Angus PW; Zhu J; Herath CB; Christophi C
    BMC Cancer; 2010 Apr; 10():134. PubMed ID: 20380732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
    Vaněčková I; Řezáčová L; Kuneš J; Zicha J
    Life Sci; 2016 Aug; 159():127-134. PubMed ID: 26775568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
    Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
    Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System.
    Kilmister EJ; Tan ST
    Front Surg; 2022; 9():868187. PubMed ID: 35574555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of key genes of the renin-angiotensin system in mature feline adipocytes and during in vitro adipogenesis.
    Riedel J; Badewien-Rentzsch B; Kohn B; Hoeke L; Einspanier R
    J Anim Physiol Anim Nutr (Berl); 2016 Dec; 100(6):1139-1148. PubMed ID: 26452529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
    Hiremath S; Fergusson DA; Fergusson N; Bennett A; Knoll GA
    Am J Kidney Dis; 2017 Jan; 69(1):78-86. PubMed ID: 27712852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.
    Esteras R; Perez-Gomez MV; Rodriguez-Osorio L; Ortiz A; Fernandez-Fernandez B
    Ther Adv Drug Saf; 2015 Aug; 6(4):166-76. PubMed ID: 26301070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease.
    Lourenço BN; Coleman AE; Berghaus RD; Tarigo JL; Schmiedt CW; Brown SA
    J Vet Intern Med; 2022 Mar; 36(2):647-655. PubMed ID: 35352404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.